KPC Pharmaceuticals,Inc. (SHA:600422)

KPC Pharmaceuticals,Inc. Revenue

KPC Pharmaceuticals,Inc. had revenue of 806.89M CNY in the quarter ending June 30, 2026, a decrease of -53.70%. This brings the company's total for the last twelve months to 4.87B, down -38.84% year-over-year. In the year 2025, KPC Pharmaceuticals,Inc. had annual revenue of 6.58B, down -21.74%. That makes KPC Pharmaceuticals,Inc. the 9,149th largest company in the world by revenue and 1,435th in China.

• Revenue (ttm): 4.87B
• Revenue Growth: -38.84%
• P/S Ratio: 1.47
• Revenue / Employee: 896.37K
• Employees: 5,072
• Market Cap: 6.67B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical Industry Segment 3.74B 53.3%
• Pharmaceutical Wholesale Division 3.27B 46.7%

By Geography

Chart

• China 6.14B 97.9%
• Foreign 133.03M 2.1%

Fiscal year ended Dec 31, 2025 See the full KPC Pharmaceuticals,Inc. breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	6.58B	-1.83B	-21.74%
Dec 31, 2024	8.40B	-28.73M	-0.34%
Dec 31, 2023	8.43B	148.11M	1.79%
Dec 31, 2022	8.28B	28.53M	0.35%
Dec 31, 2021	8.25B	536.45M	6.95%

Data Source: S&P Global Market Intelligence Last updated: Aug 21, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error